Logo image
Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV
Journal article   Open access   Peer reviewed

Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV

Jeffrey S. Barrett, Sergei Spitsin, Ganesh Moorthy, Kyle Barrett, Kate Baker, Andrew Lackner, Florin Tulic, Angela Winters, Dwight L. Evans and Steven D. Douglas
Journal of translational medicine, v 14(1), pp 148-148
26 May 2016
PMID: 27230663
url
https://doi.org/10.1186/s12967-016-0904-yView
Published, Version of Record (VoR)CC BY V4.0 Open

Abstract

Aprepitant HIV HIV associated neurocognitive disorder Inflammation Neurokinin 1 receptor SIV Substance P

Metrics

3 Record Views
18 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Industry collaboration
Domestic collaboration
Web of Science research areas
Medicine, Research & Experimental
Logo image